Can metoprolol (beta blocker) be stopped suddenly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Metoprolol Be Stopped Suddenly?

No, metoprolol should never be stopped abruptly—gradual tapering over 1-2 weeks is mandatory to prevent life-threatening complications including severe exacerbation of angina, myocardial infarction, and ventricular arrhythmias. 1

Critical Warnings About Abrupt Discontinuation

The FDA drug label explicitly warns against abrupt cessation of metoprolol therapy in patients with coronary artery disease, as severe exacerbation of angina, myocardial infarction, and ventricular arrhythmias have been reported following sudden discontinuation 1. The American College of Cardiology and American Heart Association guidelines document that beta-blocker withdrawal is associated with a 2.7-fold increased risk of 1-year mortality compared to continuous use 2. In one study, abrupt discontinuation carried a 50% mortality rate 2.

Even in patients treated only for hypertension, it may be prudent not to discontinue metoprolol therapy abruptly because coronary artery disease is common and may be unrecognized 1.

Evidence from Clinical Studies

Research demonstrates the dangers of withdrawal in specific populations:

  • In patients with dilated cardiomyopathy receiving metoprolol for ≥30 months, 7 of 13 patients deteriorated after cessation, including 4 who died suddenly or of congestive heart failure during the 4-month period following metoprolol withdrawal 3
  • Abrupt withdrawal of metoprolol is associated with a higher risk of developing beta-adrenergic receptor hypersensitivity compared to beta-blockers with intrinsic sympathomimetic activity 4

Recommended Tapering Protocol

The European Heart Journal recommends reducing the dose of metoprolol tartrate by approximately 25-50% every 1-2 weeks 2. When discontinuing chronically administered metoprolol, particularly in patients with coronary artery disease, the dosage should be gradually reduced over a period of 1-2 weeks and the patient should be carefully monitored 1.

Monitoring During Tapering

  • Monitor for signs of worsening heart failure symptoms, such as increased fatigue or shortness of breath 2
  • Monitor heart rate and blood pressure at each visit 2
  • If symptoms worsen during tapering, consider temporarily returning to the previous dose before attempting a more gradual taper 2

Special Considerations for Heart Failure Patients

For patients with heart failure, more cautious tapering may be required with smaller incremental reductions 2. The European Heart Journal recommends considering increasing diuretics or ACE inhibitors temporarily if worsening of heart failure occurs during tapering 2.

When Metoprolol Must Be Reinstated

If angina markedly worsens or acute coronary insufficiency develops during tapering, metoprolol administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken 1. Patients should be warned against interruption or discontinuation of therapy without the physician's advice 1.

Common Pitfalls to Avoid

  • Never stop metoprolol abruptly, even for symptomatic bradycardia or hypotension—dose reduction is preferred over complete cessation 2
  • Do not assume that patients without known coronary disease are safe from withdrawal complications—unrecognized coronary artery disease is common 1
  • Avoid complete discontinuation in heart failure patients—maintaining some beta-blockade at lower doses is better than no beta-blocker, as complete discontinuation increases mortality risk 2.7-fold 2

References

Guideline

Metoprolol Treatment Protocol for Hypertension and Heart-Related Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Abrupt withdrawal of pindolol or metoprolol after chronic therapy.

British journal of clinical pharmacology, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.